Results 251 to 260 of about 593,039 (291)
Some of the next articles are maybe not open access.

Melanoma

AJN, American Journal of Nursing
Melanoma incidence is rising worldwide and has doubled in Denmark over the past 25 years. Early detection is essential but challenging due to difficulties in diagnosing early melanomas and atypical nevi. This review discusses melanoma diagnostic processes in the Danish healthcare system, highlighting current and emerging diagnostic tools. More accurate
Mette, Mogensen   +6 more
openaire   +4 more sources

Melanomas

Dermatologic Clinics, 2016
Melanomas are a wide range of tumors that differ in their epidemiology, morphology, genetic profile, and biological behavior. They can be grouped as superficial spreading melanoma, lentigo maligna, and nodular melanoma. Reflectance confocal microscopy is useful for the evaluation of skin lesions that are dermoscopically doubtful by increasing ...
LONGO, Caterina, PELLACANI, Giovanni
openaire   +2 more sources

Melanoma

The Lancet, 2018
Cutaneous melanoma causes 55 500 deaths annually. The incidence and mortality rates of the disease differ widely across the globe depending on access to early detection and primary care. Once melanoma has spread, this type of cancer rapidly becomes life-threatening.
Schadendorf, Dirk   +8 more
openaire   +3 more sources

Melanoma

Hospital Medicine, 2000
Cutaneous melanoma is becoming more common. Although still rarer than some cancers it is important, particularly as it afflicts young adults relatively frequently. Furthermore early detection with resultant better prognosis should be achievable if the public was to become more aware, and if health-care professionals were more familiar with melanoma and
openaire   +2 more sources

Sorafenib in melanoma

Expert Opinion on Investigational Drugs, 2012
INTRODUCTION: Sorafenib is an orally available multi-kinase inhibitor that inhibits tumor proliferation by targeting multiple kinases including the vascular endothelial growth factor receptors VEGFR1, VEGFR2, VEGFR3 and the platelet-derived growth factor receptor PDGFR, and it targets tumor progression by inhibiting FLT3, C-Kit and BRAF.
Mangana, J   +3 more
openaire   +4 more sources

Melanoma

Facial Plastic Surgery Clinics of North America, 2013
The incidence of cutaneous malignant melanoma continues to increase worldwide. It is the deadliest form of skin malignancy. This article focuses on the epidemiology, diagnosis, prevention, and new staging criteria of melanoma. The author delves into standards of treatment and highlights new strategies, including but not limited to noninvasive imaging ...
openaire   +2 more sources

“Lentiginous Melanoma”

Advances in Anatomic Pathology, 2014
On the basis of a critical review of published literature, it is concluded that there is as yet insufficient evidence to conclude that the melanocytic lesion, which is currently known as "lentiginous melanoma," is a full-fledged melanoma, with the capacity to metastasize to distant sites and to cause the demise of the patient.
openaire   +3 more sources

Nevoid Melanoma

Surgical Pathology Clinics, 2009
This article discusses the key features of nevoid melanoma. Gross features, microscopic features, immunohistochemistry, differential diagnosis, diagnosis, prognosis, and treatment are also discussed.
A Hafeez, Diwan, Alexander J, Lazar
openaire   +3 more sources

Desmoplastic Melanoma

Clinics in Laboratory Medicine, 2009
Desmoplastic melanoma (DM) is a variant of spindle cell melanoma characterized by the presence of abundant fibrous matrix. It is typically found in the head and neck region on chronically sun-damaged skin of older individuals. Early detection is uncommon, because its clinical features are not distinctive. DM is prone to misdiagnosis not only clinically
openaire   +4 more sources

Melanoma

The Lancet, 1996
P.J. Hoskin, JasonK. Rivers
openaire   +4 more sources

Home - About - Disclaimer - Privacy